|
🐜
|
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
14 auth.
Steven J. Cohen,
C. Punt,
N. Iannotti,
B. Saidman,
K. Sabbath,
N. Gabrail,
J. Picus,
M. Morse,
E. Mitchell,
M. Miller,
...
G. Doyle,
H. Tissing,
L. Terstappen,
Neal J. Meropol
|
10 |
2008 |
10
🐜
|
|
🐜
|
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
14 auth.
Steven J. Cohen,
C. Punt,
N. Iannotti,
B. Saidman,
K. Sabbath,
N. Gabrail,
J. Picus,
M. Morse,
E. Mitchell,
M. Miller,
...
G. Doyle,
H. Tissing,
L. Terstappen,
Neal J. Meropol
|
8 |
2009 |
8
🐜
|
|
🐜
|
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
8 auth.
A. Dobs,
R. Boccia,
C. Croot,
N. Gabrail,
J. Dalton,
M. Hancock,
...
M. Johnston,
M. Steiner
|
8 |
2013 |
8
🐜
|
|
🐜
|
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.
24 auth.
R. Vij,
Michael L. Wang,
J. Kaufman,
S. Lonial,
A. Jakubowiak,
A. Stewart,
V. Kukreti,
S. Jagannath,
K. McDonagh,
M. Alsina,
...
N. Bahlis,
F. Reu,
N. Gabrail,
A. Belch,
J. Matous,
Peter P. Lee,
P. Rosen,
M. Sebag,
D. Vesole,
L. Kunkel,
Sandra Wear,
A. Wong,
R. Orlowski,
D. Siegel
|
8 |
2012 |
8
🐜
|
|
🐜
|
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
10 auth.
D. Rizzieri,
E. Feldman,
J. Dipersio,
N. Gabrail,
W. Stock,
R. Strair,
...
V. Rivera,
M. Albitar,
C. Bedrosian,
F. Giles
|
7 |
2008 |
7
🐜
|
|
🐜
|
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
20 auth.
R. W. Naumann,
R. L. Coleman,
Robert A. Burger,
E A Sausville,
E. Kutarska,
S. Ghamande,
N. Gabrail,
Stephen E. DePasquale,
E. Nowara,
L. Gilbert,
...
R. Gersh,
M. Teneriello,
W. Harb,
P. Konstantinopoulos,
R. Penson,
James T. Symanowski,
C. Lovejoy,
Christopher P. Leamon,
David E. Morgenstern,
R. Messmann
|
7 |
2013 |
7
🐜
|
|
🐜
|
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.
18 auth.
A. A. Abdul Razak,
M. Mau-Soerensen,
N. Gabrail,
J. Gerecitano,
A. Shields,
T. Unger,
J. Saint-Martin,
R. Carlson,
Y. Landesman,
D. McCauley,
...
T. Rashal,
U. Lassen,
R. Kim,
Lee-Anne Stayner,
M. Mirza,
M. Kauffman,
S. Shacham,
A. Mahipal
|
7 |
2016 |
7
🐜
|
|
🐜
|
Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.
15 auth.
R. Niesvizky,
I. Flinn,
R. Rifkin,
N. Gabrail,
V. Charu,
Billy Clowney,
J. Essell,
Y. Gaffar,
T. Warr,
R. Neuwirth,
...
Yanyan Zhu,
J. Elliott,
D. Esseltine,
L. Niculescu,
J. Reeves
|
7 |
2015 |
7
🐜
|
|
🐜
|
Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
11 auth.
R. Kurzrock,
N. Gabrail,
C. Chandhasin,
S. Moulder,
Carrie L. Smith,
A. Brenner,
...
K. Sankhala,
A. Mita,
K. Elian,
Danielle Bouchard,
J. Sarantopoulos
|
7 |
2011 |
7
🐜
|
|
🐜
|
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
20 auth.
J. Kuruvilla,
M. Savona,
R. Baz,
P. M. Mau-Sørensen,
N. Gabrail,
R. Garzon,
R. Stone,
Michael L. Wang,
L. Savoie,
P. Martin,
...
I. Flinn,
Meagan A. Jacoby,
T. Unger,
J. Saint-Martin,
T. Rashal,
S. Friedlander,
R. Carlson,
M. Kauffman,
S. Shacham,
M. Gutierrez
|
7 |
2017 |
7
🐜
|
|
🐬
|
A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain
R. Portenoy,
A. Burton,
N. Gabrail,
Donald H. Taylor
|
7 |
2010 |
7
🐬
|
|
🐜
|
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
23 auth.
C. Walker,
J. Oaks,
R. Santhanam,
P. Neviani,
Jason G. Harb,
Gregory Ferenchak,
Justin J Ellis,
Y. Landesman,
Ann-Kathrin Eisfeld,
N. Gabrail,
...
Carrie L. Smith,
M. Caligiuri,
P. Hokland,
D. Roy,
A. Reid,
D. Milojkovic,
J. Goldman,
J. Apperley,
R. Garzon,
G. Marcucci,
S. Shacham,
M. Kauffman,
D. Perrotti
|
6 |
2013 |
6
🐜
|
